Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 17, 2023 13:00 ET | Source: DelveInsight Business Research LLP

Attention Deficit Hyperactivity Disorder Clinical Trials Pipeline Analysis: 20+ Companies are Working to Improve the Treatment Space | DelveInsight

New York, USA, July 17, 2023 (GLOBE NEWSWIRE) -- Attention Deficit Hyperactivity Disorder Clinical Trials Pipeline Analysis: 20+ Companies are Working to Improve the Treatment Space | DelveInsight ...
July 24, 2012 08:35 ET | Source: P2D Bioscience

Advinus Therapeutics and P2D Bioscience Enter Into a Research and Development Collaboration for Attention Deficit Hyperactivity Disorder (ADHD)

CINCINNATI, OH and BANGALORE, INDIA--(Marketwire - Jul 24, 2012) - Advinus Therapeutics Ltd., a drug discovery and development company, and P2D Bioscience, a CNS-focused specialty...
April 26, 2011 10:15 ET | Source: P2D Bioscience

P2D Bioscience Announces Enhanced Patent Position for Lead ADHD Drug

CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Apr 26, 2011) - www.p2dinc.com ...
April 12, 2011 08:00 ET | Source: P2D Bioscience

P2D Bioscience Lead ADHD Drug Demonstrates Efficacy in Preclinical Testing

CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Apr 12, 2011) - P2D Bioscience (P2D, Inc.), a pharmaceutical development company, today announced that its lead Attention Deficit/Hyperactivity Disorder...